Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from a Pre-Pivotal Postcoital Test Study of Ovaprene®: an Investigational Hormone-Free Monthly Intravaginal Contraceptive
GlobeNewswire
*Published data shows that Ovaprene was safe and effective in a postcoital test study of 33 women *
*Pivotal Phase 3..